These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 18506391)
41. The function of dopaminergic neural signal transmission in auditory pulse perception: evidence from dopaminergic treatment in Parkinson's patients. Geiser E; Kaelin-Lang A Behav Brain Res; 2011 Nov; 225(1):270-5. PubMed ID: 21787806 [TBL] [Abstract][Full Text] [Related]
42. Dopamine improves exploration after expectancy violations and induces psychotic-like experiences in patients with Parkinson's disease. Polner B; Moustafa AA; Nagy H; Takáts A; Győrfi O; Kéri S Neurosci Lett; 2016 Mar; 616():132-7. PubMed ID: 26820375 [TBL] [Abstract][Full Text] [Related]
43. Safinamide for the treatment of Parkinson's disease. Kandadai RM; Jabeen SA; Kanikannan MA; Borgohain R Expert Rev Clin Pharmacol; 2014 Nov; 7(6):747-59. PubMed ID: 25300164 [TBL] [Abstract][Full Text] [Related]
45. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. Parkinson Study Group JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889 [TBL] [Abstract][Full Text] [Related]
46. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease. Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199 [TBL] [Abstract][Full Text] [Related]
47. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611 [TBL] [Abstract][Full Text] [Related]
48. Dopaminergic modulation of motor network dynamics in Parkinson's disease. Michely J; Volz LJ; Barbe MT; Hoffstaedter F; Viswanathan S; Timmermann L; Eickhoff SB; Fink GR; Grefkes C Brain; 2015 Mar; 138(Pt 3):664-78. PubMed ID: 25567321 [TBL] [Abstract][Full Text] [Related]
49. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication. Evens R; Hoefler M; Biber K; Lueken U Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264 [TBL] [Abstract][Full Text] [Related]
57. Motor program memory storage in Parkinson's disease patients tested with a delayed response task. Labutta RJ; Miles RB; Sanes JN; Hallett M Mov Disord; 1994 Mar; 9(2):218-22. PubMed ID: 8196687 [TBL] [Abstract][Full Text] [Related]
58. Working memory in Parkinson's disease patients: clinical features and response to levodopa. Beato R; Levy R; Pillon B; Vidal C; du Montcel ST; Deweer B; Bonnet AM; Houeto JL; Dubois B; Cardoso F Arq Neuropsiquiatr; 2008 Jun; 66(2A):147-51. PubMed ID: 18545772 [TBL] [Abstract][Full Text] [Related]
59. Dopamine modulation affects the performance of parkinsonian patients in a precision motor task measured by an antropomorphic device. Nombela C; Pedreño-Molina JL; Ros-Bernal F; Molina-Vilaplana J; Fdez-Villalba E; López-Coronado J; Herrero MT Hum Mov Sci; 2012 Jun; 31(3):730-42. PubMed ID: 22414696 [TBL] [Abstract][Full Text] [Related]
60. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]